SCHEMBL16055064

SCHEMBL16055064

CC(C)C(O)[CH]c1ccc(Cl)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.47
▸ GABRA1 P14867 1/20 0.45
▸ GABRG2 P18507 1/20 0.45
▸ GABRB3 P28472 1/20 0.45
▸ MAPT P10636 4/20 0.41
▸ GRIN2D O15399 2/20 0.41
▸ GRIN3B O60391 2/20 0.41
▸ GRIN1 Q05586 2/20 0.41
▸ GRIN2A Q12879 2/20 0.41
▸ GRIN2B Q13224 2/20 0.41
▸ GRIN2C Q14957 2/20 0.41
▸ GRIN3A Q8TCU5 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ TP53 P04637 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15066556 0.85 TDP1 (0.50) TDP1GABRA1GABRG2GABRB3MAPT
SCHEMBL18244067 0.80 TDP1 (0.54) TDP1GABRA1GABRG2GABRB3MAPT
SCHEMBL246480 0.76 TDP1 (0.46) TDP1GABRA1GABRG2GABRB3MAPT
SCHEMBL249814 0.76 TDP1 (0.46) TDP1GABRA1GABRG2GABRB3MAPT
SCHEMBL15066089 0.71 TDP1 (0.41) TDP1GABRA1GABRG2GABRB3MAPT
SCHEMBL16054819 0.71 TDP1 (0.41) TDP1GABRA1GABRG2GABRB3MAPT
SCHEMBL9412002 0.70 MAPT (0.43) TDP1GABRA1GABRG2GABRB3MAPT
SCHEMBL9412000 0.70 MAPT (0.43) TDP1GABRA1GABRG2GABRB3MAPT
SCHEMBL9412005 0.70 MAPT (0.43) TDP1GABRA1GABRG2GABRB3MAPT
SCHEMBL10321775 0.69 TDP1 (0.50) TDP1GABRA1GABRG2GABRB3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968213-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING A MOVEMENT DISORDER Bio-Pharm Solutions Co., Ltd. (KR) 2016-01-20 — — EP claimed
EP-2968212-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME Bio-Pharm Solutions Co., Ltd. (KR) 2016-01-20 — — EP claimed
WO-2014142520-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2014-09-18 — — WO claimed
WO-2014142518-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING A MOVEMENT DISORDER BIO-PHARM SOLUTIONS CO., LTD. (KR) 2014-09-18 — — WO claimed
EP-2968213-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING A MOVEMENT DISORDER Bio-Pharm Solutions Co., Ltd. (KR) 2016-01-20 — — EP disclosed
WO-2014142518-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING A MOVEMENT DISORDER BIO-PHARM SOLUTIONS CO., LTD. (KR) 2014-09-18 — — WO disclosed
Send feedback